These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1387399)

  • 1. Formation and structure of the C5b-7 complex of the lytic pathway of complement.
    DiScipio RG
    J Biol Chem; 1992 Aug; 267(24):17087-94. PubMed ID: 1387399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH; Hänsch G; Gresham HD; Shin ML
    J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of human complement component C7 and the C5b-7 complex.
    DiScipio RG; Chakravarti DN; Muller-Eberhard HJ; Fey GH
    J Biol Chem; 1988 Jan; 263(1):549-60. PubMed ID: 3335508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete primary structure and functional characterization of the sixth component of the human complement system. Identification of the C5b-binding domain in complement C6.
    Haefliger JA; Tschopp J; Vial N; Jenne DE
    J Biol Chem; 1989 Oct; 264(30):18041-51. PubMed ID: 2808363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.
    Stewart JL; Kolb WP; Sodetz JM
    J Immunol; 1987 Sep; 139(6):1960-4. PubMed ID: 3624872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement components C5 and C7: recombinant factor I modules of C7 bind to the C345C domain of C5.
    Thai CT; Ogata RT
    J Immunol; 2004 Oct; 173(7):4547-52. PubMed ID: 15383587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activation of human complement component C5 by a fluid phase C5 convertase.
    DiScipio RG; Smith CA; Muller-Eberhard HJ; Hugli TE
    J Biol Chem; 1983 Sep; 258(17):10629-36. PubMed ID: 6554279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolysis of the C5b-7 complex: cleavage of the C5b and C6 subunits and its effect on the interaction of the complex with phospholipid bilayers.
    Yamamoto KI
    J Immunol; 1980 Oct; 125(4):1745-50. PubMed ID: 6997387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The terminal membrane C5b-9 complex of human complement. Evidence for the existence of multiple protease-resistant polypeptides that form the trans-membrane complement channel.
    Bhakdi S; Tranum-Jensen J; Klump O
    J Immunol; 1980 May; 124(5):2451-7. PubMed ID: 6154104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage of the fifth component of complement and generation of a functionally active C5b6-like complex by human leukocyte elastase.
    Vogt W
    Immunobiology; 2000 Jan; 201(3-4):470-7. PubMed ID: 10776801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant C345C and factor I modules of complement components C5 and C7 inhibit C7 incorporation into the complement membrane attack complex.
    Thai CT; Ogata RT
    J Immunol; 2005 May; 174(10):6227-32. PubMed ID: 15879120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a two-domain structure of the terminal membrane C5b-9 complex of human complement.
    Bhakdi S; Tranum-Jensen J
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5872-6. PubMed ID: 293689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of human C5 by trypsin: characterization of the digestion products by gel electrophoresis.
    Minta JO; Man DP
    J Immunol; 1977 Nov; 119(5):1597-1602. PubMed ID: 410877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The killer molecule of complement.
    Müller-Eberhard HJ
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):47s-52s. PubMed ID: 3891882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA
    Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH; Abramovitz AS; Mayer MM
    J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human monocyte spreading induced by activated factor B of the complement alternative pathway: differential effects of Fab' and F(ab')2 antibody fragments directed to C5, C6, and C7.
    Sundsmo JS; Götze O
    Cell Immunol; 1983 Apr; 77(1):176-86. PubMed ID: 6601526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmembrane channel-formation by five complement proteins.
    Müller-Eberhard HJ
    Biochem Soc Symp; 1985; 50():235-46. PubMed ID: 2428370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and characterization of the C345C/NTR domains of complement components C3 and C5.
    Thai CT; Ogata RT
    J Immunol; 2003 Dec; 171(12):6565-73. PubMed ID: 14662858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.